Products for Research Use Only
RegisterLogin

ATI22-107

CAT: 0804-HY-126763Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-126763Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ATI22-107 is a dual-pharmacophore compound designed to simultaneously inhibit cardiac phosphodiesterase (PDE-III) and L-type calcium channels (LTCC), with activity that has specific effects on calcium cycling and contractility in cat ventricular myocytes and trabeculae.
CAS Number
681816-57-9
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ati22-107.html
Smiles
O=C(C1=C(COCCNC(COC2=CC=C(C(CC3)=NNC3=O)C=C2Cl)=O)NC(C)=C(C(OC)=O)C1C4=CC=CC=C4Cl)OC
Molecular Formula
C31H32Cl2N4O8
Molecular Weight
659.51
References & Citations
[1]Pharmacological effects of ATI22-107 [2- (2-{2-[2-chloro-4- (6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl) -phenoxy]-acetylamino}-ethoxymethyl) -4- (2-chloro-phenyl) -6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid dimethyl ester) ], a novel dual pharmacophore, on myocyte calcium cycling and contractility
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P991328MAb604.107
HY-P10692HB-107
HY-106806NZ-107
HY-163396EGFR-IN-107
HY-P991272-01ATR-107
HY-167893AGH-107
HY-108038-01ABT-107
HY-168649-01JH-LPH-107
HY-149896Antitumor agent-107
HY-147546Antibacterial agent 107

Alternative Products

CatalogName
BA6827-10ABT-107
T201735-01AGH-107
T9901A-1007-01ATR-107
GTR19240838-01TJA-107
GTR19233371-01TR-107
GTR19274275-01α-Glucosidase-IN-107
T9901A-1601-01MAb604.107
TP2932-01HB-107
MBS131174-01NM-107
MBS5814037NZ-107

Popular Products